Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
604.00    -5.00 (-0.82%)
Bid:
603.00
Ask:
605.00
Spread: 2.00 (0.332%)
Market Cap: £526.23m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

‘Magma’ advances via TechnipFMC award

7 May 2025 07:00

RNS Number : 5728H
Victrex PLC
07 May 2025
 

May 7, 2025

Victrex plc

Victrex's 'Magma' mega-programme advances via technological contract award for TechnipFMC

Victrex plc, an innovative world leader in high performance polymer solutions, delivering sustainable products which support CO2 reduction and bring environmental and societal benefit, today welcomes the announcement by TechnipFMC following its 'ETEC' technological contract award by Petrobras in Brazil. This order supports the pathway towards a significant multi-year opportunity for Victrex's 'Magma' mega-programme, which is based on VictrexTM PEEK polymer, Victrex composite tape and Victrex pipe extrusion know-how.

TechnipFMC's hybrid flexible pipe (HFP) incorporates a carbon fibre thermoplastic composite pipe based on VictrexTM PEEK polymer, Victrex composite tape and Victrex's pipe extrusion capabilities. HFP offers the advantages of flexible pipe, whilst providing a lighter and corrosion-resistant solution, with faster installation and sustainability benefits. TechnipFMC's technological order with Petrobras seeks to accelerate the development and commercialisation of HFP as a standardised definitive solution for stress corrosion cracking by CO2 (SCC CO2) experienced with flexible pipe systems used today.

Victrex has a long-standing and exclusive supply relationship to TechnipFMC, as well as working closely through HFP's qualification phase. Victrex was previously a minority shareholder in Magma Global - acquired by TechnipFMC in 2021 - to help enable new markets and support development of PEEK-based composite pipe in the energy industry.

Jakob Sigurdsson, Chief Executive of Victrex, said: "This is a major commercial milestone. It builds on the progress achieved during the qualification phase and is good news for Victrex and our 'Magma' mega-programme. This will help to enable and accelerate a high performance, sustainable, durable and VictrexTM PEEK-based alternative for the industry, as well as the opportunity to bring a new solution for other oil & gas fields.

"Hybrid Flexible Pipe demonstrates the wide-ranging benefits of VictrexTM PEEK materials, with significant know-how involved. We look forward to supporting all parties to deliver and scale-up on this sizeable growth opportunity."

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications +44 (0) 1253 898121

+44 (0) 7809 595831

Jakob Sigurdsson, Chief Executive +44 (0) 1253 897700

Ian Melling, Chief Financial Officer +44 (0) 1253 897700

 

Notes:

1/ The ETEC technological order used by Petrobras is a form of public procurement aimed at developing innovative products or services. It enables the Brazilian government to stimulate innovation, through initial funding, with subsequent direct procurement of the developed product or service.

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the end-markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our sustainable materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 40 years' experience, we innovate in polymers, semi-finished and finished products which provide environmental and societal benefit for our customers and drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUUWAUPAGMQ
Date   Source Headline
29th May 202611:00 amRNSTotal Voting Rights
18th May 20268:50 amRNSDirectorate change
11th May 20267:00 amRNSHalf-year Financial Report
30th Apr 202610:46 amRNSTotal Voting Rights
29th Apr 20264:28 pmRNSHolding(s) in Company
31st Mar 20261:37 pmRNSTotal Voting Rights
24th Mar 20264:29 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
20th Mar 20269:38 amRNSHolding(s) in Company
27th Feb 20262:40 pmRNSTotal Voting Rights
27th Feb 20261:02 pmRNSHolding(s) in Company
24th Feb 202611:41 amRNSHolding(s) in Company
17th Feb 20263:06 pmRNSDirector/PDMR Shareholding
12th Feb 20263:26 pmRNSDirector/PDMR Shareholding
12th Feb 20263:22 pmRNSDirector/PDMR Shareholding
10th Feb 20262:43 pmRNSDirector/PDMR Shareholding
10th Feb 20269:00 amRNSDirectorate change
6th Feb 20261:33 pmRNSResult of AGM
6th Feb 20267:00 amRNSQ1 Trading Update
30th Jan 202611:49 amRNSTotal Voting Rights
28th Jan 202612:25 pmRNSHolding(s) in Company
22nd Jan 202610:21 amRNSHolding(s) in Company
20th Jan 20261:26 pmRNSAdditional Listing
31st Dec 20259:00 amRNSTotal Voting Rights
31st Dec 20259:00 amRNSTotal Voting Rights
22nd Dec 202512:00 pmRNSAnnual Financial Report
22nd Dec 202512:00 pmRNSAnnual Financial Report
18th Dec 202511:49 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20253:42 pmRNSDirector/PDMR Shareholding
17th Dec 202512:08 pmRNSDirector/PDMR Shareholding
15th Dec 20259:00 amRNSDirector/PDMR Shareholding
11th Dec 20258:52 amRNSDirector/PDMR Shareholding
5th Dec 20259:30 amRNSShare purchase by incoming Director (incoming CEO)
4th Dec 20259:06 amRNSFinancial Calendar Update
2nd Dec 20257:00 amRNSPreliminary Results
1st Dec 202510:49 amRNSBlock listing Interim Review
28th Nov 20259:27 amRNSTotal Voting Rights
20th Nov 20259:05 amRNSAdditional Listing
7th Nov 202510:39 amRNSHolding(s) in Company
31st Oct 20258:58 amRNSTotal Voting Rights
21st Oct 20257:30 amRNSCEO Succession update
3rd Oct 202511:36 amRNSHolding(s) in Company
3rd Oct 20259:03 amRNSHolding(s) in Company
30th Sep 20259:54 amRNSTotal Voting Rights
29th Aug 202510:16 amRNSTotal Voting Rights
31st Jul 20259:14 amRNSTotal Voting Rights
9th Jul 20251:02 pmRNSHolding(s) in Company
8th Jul 20253:33 pmRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSDirectorate change: CEO succession
8th Jul 20257:00 amRNSQ3 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.